Travere Therapeutics Stock Quote TVTX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

18.68

Bid

17.51

Ask

19.80

Volume

0.00 Day's Range 0.00

5.12 52 Week Range 20.33

Market Cap

1.458B

Previous Close

18.68

Open

Last Trade

19.17

Last Trade Time

06:16:28

Financial Volume

VWAP

Average Volume (3m)

1,697,061

Shares Outstanding

78,049,928

Dividend Yield

PE Ratio

-13.09

Earnings Per Share (EPS)

-1.43

Revenue

145.24M

Net Profit

-111.4M

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

travere.com

Headquarters

Lewes, Delaware, USA

Founded

Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was $18.68. Over the last year, Travere Therapeutics shares have traded in a share price range of $ 5.12 to $ 20.33.

Travere Therapeutics currently has 78,049,928 shares outstanding. The market capitalization of Travere Therapeutics is $1.46 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -13.09.

Overall Flow

Bullish

Net Premium

86k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

FeaturedActelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market Eyes Trillions and Infrastructure Cyber Security Gains Importance - $ASNS

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the completion of its previously announced underwritten public offering of 8,984,375 shares...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.51	-2.65763418447	19.19	19.79	17.685	1001664	18.9104987	CS
4	0.12	0.646551724138	18.56	19.99	16.86	1147612	18.54903176	CS
12	3.99	27.161334241	14.69	20.33	13.24	1697061	16.94961992	CS
26	11.26	151.752021563	7.42	20.33	6.8	1504287	13.74247502	CS
52	10.02	115.704387991	8.66	20.33	5.12	1380713	11.03698269	CS
156	-7.95	-29.8535486294	26.63	31.65	5.12	1192023	15.43718879	CS
260	-6.47	-25.7256461233	25.15	33.0899	5.12	1080935	16.60207791	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PALIPalisade Bio Inc	$ 3.21 (129.29%)	19.72M
TRVITrevi Therapeutics Inc	$ 3.55 (42.57%)	1.91M
SYTASiyata Mobile Inc	$ 1.01 (35.03%)	11.27M
CDTConduit Pharmaceuticals Inc	$ 0.112 (26.84%)	11.65M
MDCXMedicus Pharma Ltd	$ 3.44 (22.86%)	548
KROSKeros Therapeutics Inc	$ 19.10 (-72.18%)	533.94k
SPGCSacks Parente Golf Inc	$ 0.5563 (-60.26%)	116.09k
PNBKPatriot National Bancorp Inc	$ 1.08 (-58.78%)	16
AVGRAvinger Inc	$ 0.455 (-44.51%)	84.16k
SFHGSamfine Creation Holdings Group Ltd	$ 1.81 (-40.66%)	276.5k
PALIPalisade Bio Inc	$ 3.21 (129.29%)	19.72M
AMPGAmplitech Group Inc	$ 2.30 (19.17%)	13.23M
CDTConduit Pharmaceuticals Inc	$ 0.112 (26.84%)	11.65M
SYTASiyata Mobile Inc	$ 1.01 (35.03%)	11.27M
LAESSEALSQ Corporation	$ 1.29 (12.17%)	8.46M